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Abstract
Background: patients with palliative needs often experience high symptom burden which causes suffering to
themselves and their families. Depression and psychological distress should not be considered a “normal event” in
advanced disease patients and should be screened, diagnosed, acted on and followed-up. Psychological distress
has been associated with greater physical symptom severity, suffering, and mortality in cancer patients. A holistic,
but short measure should be used for physical and non-physical needs assessment. The Integrated Palliative care
Outcome Scale is one such measure. This work aims to determine palliative needs of patients and explore
screening accuracy of two items pertaining to psychological needs.
Methods: multi-centred observational study using convenience sampling. Data were collected in 9 Portuguese
centres. Inclusion criteria: ≥18 years, mentally fit to give consent, diagnosed with an incurable, potentially life-
threatening illness. Exclusion criteria: patient in distress (“unable to converse for a period of time”), cognitively
impaired. Descriptive statistics used for demographics. Receiving Operator Characteristics curves and Area Under
the Curve for anxiety and depression discriminant properties against the Hospital Anxiety and Depression Scale.
Results: 1703 individuals were screened between July 1st, 2015 and February 2016. A total of 135 (7.9%) were
included. Main reason for exclusion was being healthy (75.2%). The primary care centre screened most individuals,
as they have the highest rates of daily patients and the majority are healthy. Mean age is 66.8 years (SD 12.7), 58
(43%) are female. Most patients had a cancer diagnosis 109 (80.7%). Items scoring highest (=4) were: family or
friends anxious or worried (36.3%); feeling anxious or worried about illness (13.3%); feeling depressed (9.6%). Using a
cut-off score of 2/3, Area Under the Curve for depression and anxiety items were above 70%.
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Conclusions: main palliative needs were psychological, family related and spiritual. This suggests that clinical teams
may better manage physical issues and there is room for improvement regarding non-physical needs. Using the
Integrated Palliative care Outcome Scale systematically could aid clinical teams screening patients for distressing
needs and track their progress in assisting patients and families with those issues.
Keywords: Palliative care, Screening accuracy, Depression, Anxiety, Patient centred outcome measures, Outcome
measurement, End of life care, Suffering
Background
Palliative care is a holistic approach of care, which can
be integrated early in the disease trajectory, alongside ac-
tive, curative treatment, [1] and aims to alleviate physical
and non-physical symptoms of patients and their fam-
ilies [2–7]. Though physical symptoms may be more eas-
ily identified by healthcare professionals, patients and
carers, non-physical symptoms can equally disrupt the
patient and family’s quality of life and cause suffering
[8]. Regarding effectiveness of psychological interven-
tions to improve quality of life in people with long term
conditions, results from a rapid systematic review show
that there was a significant improvement in at least one
quality of life outcome post-intervention and maintained
at follow-up [9]. In another study, Ann-Yi S and col-
leagues report that 24% of palliative care in-patients and
19% of palliative care outpatients in a major cancer
centre benefited from psychology services [8]. Also, psy-
chological distress has been associated with greater
physical symptom severity, suffering, and mortality in
cancer patients [10]. Thus, these symptoms and needs
should be properly assessed with validated outcome
measures, and, the intervention(s) to solve or manage
them should be selected accordingly [11, 12]. Depression
and psychological distress are two examples of such
needs, which should not be considered a “normal event”
in an advanced disease trajectory [13]. Rather, they
should be screened, diagnosed, acted on and followed-
up by appropriate support services and specialised
healthcare professionals, whether by pharmacologic
treatment, psychological treatment, psychiatric treat-
ment or a combination of those [13]. Patient centred
outcome measures should be the first choice to measure
subjective symptoms and needs, given that the patient is
the best person to assess how the symptoms bother
them. If the patient is cognitively impaired, a proxy ver-
sion of the measure of choice can be used [14–18].
These measures are short, but multidimensional and
some items may be used to screen for certain palliative
needs, common in this population [19].
The aim of this study is to determine the main pallia-
tive care needs of patients being treated in portuguese
health care services and to explore screening properties
of two items pertaining to psychological needs, using the
Integrated Palliative care Outcome Scale (IPOS) [20, 21].
We hypothesized that 1) anxiety and depression items
will score highest among the non physical symptoms
and 2) the area under the curve (AUC) to be > 0.7 for
Items 3 (anxiety) and 5 (depression) in relation to the
Portuguese Hospital Anxiety and Depression Scale
(HADS) [22] Anxiety subscale score and the HADS-
Depression subscale total scores, respectively.
Methods
Patients and settings
This was a multi-centred observational study. Data were
collected in nine portuguese centres spread out from
north to south and rural to urban locations to maximise
generalizability using convenience sampling. There were
seven hospital based palliative care services, one oncol-
ogy service and one primary care facility (health centre).
All patients attending the participant services were
screened for eligibility by the participating healthcare
professionals. Inclusion criteria were as follows: ≥18
years, mentally fit to give consent judged as such by the
participating healthcare professional, diagnosed with an
incurable, potentially life-threatening illness, read, write
and understand Portuguese. Exclusion criteria were: pa-
tient in distress (unable to maintain a conversation dur-
ing a period of time) with uncontrolled physical or
emotional symptoms, and/or cognitively impaired,
judged as such by the participating healthcare profes-
sional. A standard operating procedures manual was de-
veloped and distributed to all centres in the person of
the facilitator/champion leading the study locally. The
detailed protocol has been published elsewhere [18].
Measures
The Portuguese version of the IPOS reported by the pa-
tient, previously developed, was used. The original meas-
ure has been culturally adapted and validated to
European Portuguese [20, 21]. The protocol of the latter
study has been published elsewhere [18] which contains
the full questionnaire in the appendix. Next, we present
a summary of main procedures and results. Two native
Portuguese speaking translators, one clinical and one
non-clinical independently created two Portuguese ver-
sions. A consensus Portuguese version was developed by
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two native Portuguese speaking independent reviewers
blind to the original IPOS. This consensus version was
sent to two other independent native Portuguese speak-
ing translators, also blind to the original English IPOS,
who back translated it into English. A second Portuguese
consensus version was developed by the same reviewers.
Three clinical revisions were performed by one specialist
palliative care doctor, one specialist palliative care nurse
and one non-clinical researcher – all native Portuguese.
A final Portuguese version was created. There were gram-
matical and content differences in the first translation stage,
in the items/questions text as well as in the response cat-
egories. These were resolved by discussion by both re-
viewers. There were also differences in the backward
translation, namely verb tenses and the use of synonyms ra-
ther than the direct translation of words. These were re-
solved by discussion by the same reviewers. The clinical
revisions flagged differences in verb tenses in three items.
Those were discussed, and changes were made to create
the final version. A Portuguese version of the IPOS was de-
veloped. Next, psychometric characteristics were assessed,
namely, Internal consistency (excluding open questions,
which are free text data) Cronbach’s alpha varied between
0.68 and 0.72, reliability between patients and healthcare
professionals scores was assessed by intraclass correlation
which was higher for mobility (ICC = 0.726 and lowest for
practical problems (ICC = 0.088). Regarding construct val-
idity, Items with similar constructs showed convergent val-
idity and items with different constructs showed divergent
validity. Spearman’s Rho varied between .390 and .631 with
p ≤ .000. The measure also displayed good sensitivity to
change, as Wilcoxon ranked test showed significant statisti-
cally differences between T1 and T2 in three symptoms.
IPOS It is a brief, 19-item, multidimensional scale that cap-
tures core concerns in palliative care. The first item is an
open question on the three main problems or worries the
respondent might have had in the past week (results of this
item are not reported in the present study given that data
are free text); items 2 to 9 are set on a 5 point Likert scale
based on descriptors (zero – not at all, 1 – slightly, 2 –
moderately, 3 – severely, 4 – overwhelmingly), item two is
a list of 10 of the most common physical symptoms in a
palliative population, with the possibility of adding up to
three more symptoms which are not present in the list;
item 3 pertains to anxiety, item 4 asks about family/friends
worry, item 5 is on depression; item 6 is about being at
peace; item 7 relates to sharing feelings with significant
people; item 8 is about information needs and item 9 con-
cerns practical problems related to their illness. In the pa-
tient version (as opposed to the healthcare professional
version), the questionnaire has an extra item asking if the
respondent filled the questionnaire alone or with help. At
the very end, there is a footnote to trigger the patient to talk
to their healthcare professional, if they feel they are worried
about any of the issues raised by the items in the question-
naire. This feature allows for real time clinical utility of the
measure.
The Portuguese Hospital Anxiety and Depression
Scale (HADS) is a 14 item screening measure for anxiety
and depression states. The two subscales are comprised
of 7 items each, scored separately, with descriptive an-
swers based in a 4 point Likert scale. The authors
propose a cut-off threshold of 11 for depression and
anxiety. The authors conclude that the Portuguese
HADS is a reliable and valid measure for assessing anx-
iety and depression in different medical settings and dis-
ease populations [22].
Analysis
After checking data quality and performing Little’s Miss-
ing Completely At Random (MCAR) test to check if data
were missing at random, descriptive statistics were used
to examine the distribution of demographic and clinical
variables of interest. To determine accuracy of the items
under study, we previously tested all possible cut-offs
(results not presented) and decided to use the most ap-
propriate, a cut-off score of 2/3. Then we compared all 5
psychological, emotional and spiritual needs items (IPOS
items 3 to 7) against the Portuguese HADS. Receiver op-
erating characteristic curves (ROC) were used to deter-
mine the 2 items displaying the highest AUC and assess
discriminant properties, namely, sensitivity and specifi-
city of the cut-off 2/3 for both items against cut-off 10/
11 of the HADS Anxiety subscale and the HADS De-
pression subscale respectively. Positive (PPV) and nega-
tive predictive values (NPV), false negative (FNR) and
false positive rates (FPR) and positive and negative likeli-
hood ratios weighted by prevalence were also computed
for both items. For sensitivity, specificity, PPV, and NPV
we considered 70% or above values to be acceptable and
80% or above to be high. For FPR and FNR of 30% or
less, we considered them to be low. 95% confidence in-
tervals were used. No sample size calculation was per-
formed given that the only study found in the literature
used the Palliative care Outcome Scale questionnaire
(not the IPOS) and the HADS to screen for depression
and anxiety was a secondary analysis of several inde-
pendent datasets.
Ethics procedures
Ethical approval was granted from all relevant Research
Ethics Committees and was in accordance with the 1964
Helsinki declaration and its later amendments or com-
parable ethical Standard. All participants gave informed
signed consent. SPSS, version 22 (SPSS/IBM Corp.,
Armonk, NY) software was used.
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Results
A total of 1703 individuals were screened between July
1st, 2015 and February 2016, the majority of which in a
health centre, a primary health care facility. There were
18 (1.1%) patients eligible for the study who declined
participation and 140 (8.2%) were excluded. A total of
135 (7.9%) patients were included (See Table 1).
Main reason for exclusion was being healthy (75.2%).
This is expected given that the primary care centre
screened most individuals, as they have the highest rates
of daily patients and most of them are healthy. Mean
age is 66.8 years (SD 12.7), 58 (43%) are female, 74
(54.8%) have up to 4 years of formal education, 74
(54.8%) are from the Northern region. Most patients
(N = 109, 80.7%) had a cancer diagnosis and came from
the 7 hospital palliative care services (See Table 2).
The main reasons for ineligibility and exclusion from
the study are presented in Table 3. Most patients were
approached to participate in the study whilst in external
consultation, 98 (72.6%). About 31.1% were able to fill
the questionnaires without help.
Data were missing at random (Little’s MCAR test
showed Chi-Square = 2452.946, DF = 2398, Sig. = .213).
Missing data varied between 1 and 5% (rates < 1% are triv-
ial, 1–5% are manageable, 5–15% require sophisticated
statistical methods to handle, and > 15% may severely im-
pact any form of interpretation.) [23]. As expected in pal-
liative populations, most questionnaire items presented a
non-parametric distribution, so the imputation of the me-
dian was used to handle missing data.
Prevalence of needs
In terms of prevalence of needs, IPOS items scoring
the highest (=4) were: family or friends anxious or
worried (36.3%); feeling anxious or worried about ill-
ness (13.3%); feeling depressed (9.6%); feeling at peace
(9.6%); share feelings (8.9%) and pain (7.4%). IPOS
items scoring the lowest (=0) were: vomiting (77%);
shortness of breath (67.4%); nausea (65%); information
needs (60.7); practical problems (45.2%) and constipa-
tion (43%). (See Fig. 1).
Screening for anxiety and depression
Item 3 (anxiety) and item 5 (depression) presented the
highest AUCs (see Fig. 2). The prevalence of depression
was 24.4% (C.I. 17.6–32.7%). The AUC curve was 0.72
Table 1 Patients screened and included in the study by
participating centre
Participating services Screened N (%) Included N (%)
Oncology Hospital service 78 (4.6) 25 (18.5)
Palliative care service 1 north 96 (5.6) 9 (6.7)
Palliative care service 2 north 28 (1.6) 17 (12.6)
Palliative care service 3 south 18 (1.1) 1 (0.7)
Palliative care service 4 north 77 (4.5) 24 (17.8)
Palliative care service 5 south 64 (3.8) 17 (12.6)
Primary care centre 1 south 119 (7.0) 3 (2.2)
Primary care centre 2 south 1177 (69.1) 25 (18.5)
Palliative care service 6 centre 46 (2.7) 14 (10.4)
Total 1703 (100) 135 (100)
Table 2 Demographic and clinical information of participants
Demographic and clinical information N(%)
Mean Age in years (SD) 66.8 (12.7)
Gender Male 77 (57%)
Education (in years) Reads and writes 5 (3.7)
4 years 81 (60)
6 years 20 (14.8)
9 years 10 (7.4)
10 years to college 19 (14)
Geographical region North 74 (54.8)
Centre 25 (18.5)
South 36 (26.7)
Area Urban 94 (69.6)
Peri-urban 31 (23)
Rural 10 (7.4)
Place of care Primary care 28 (20.7%)
hospital services 25 (18.5%)
palliative care services 82 (60.7%)
Cancer Diagnosis 109 (80.7)
Phase of illness Stable 64 (47.4)
Unstable 28 (20.7)
Deteriorating 43 (31.9)
Terminal
Surprise question (life expectancy) > 1 year 37 (27.4)
6 m to 1 year 45 (33.3)
< 6 months 48 (35.6)
Table 3 Reasons for ineligibility and exclusion
Reasons for ineligibility and exclusion N (%)
Ineligible < 18 years 91 (5.9)
Does not understand Portuguese 1 (0.06)
Cannot read or write 78 (5.0)
Illness with possibility of cure 3 (0.2)
Healthy 1165 (75.2)
No reason stated 72 (4.6)
Excluded Distress 52 (3.4)
Cognitive deterioration 73 (4.7)
No reason stated 15 (0.9)
Total 1550 (100)
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(C.I.:0.62–0.81), p < 0.001 (see Fig. 3). Sensitivity was
51.5% and specificity was 78.4%. Positive predictive value
was 43.6% and negative predictive value was 83.3%. As for
the anxiety item, the prevalence was 23.7% (C.I.
16.9%–.31.9%) and the AUC was 0.70 (C.I.:0.60–0.80), p <
0.001 (see Fig. 4). Sensitivity was 65.6% and specificity was
68.0%. Positive predictive value was 38.8% and negative
predictive value was 86.4% (see Table 4).
Discussion
The main palliative needs of patients cared for by pallia-
tive care teams were psychological, family related and
spiritual. IPOS systematically identified main needs in
this population. Clinical teams seemed to solve or man-
age physical issues well. This is an extremely positive
find. There is evidence that once physical needs are well
managed, and the patient is more comfortable, non-
Fig. 1 IPOS scores for prevalence of main palliative needs
Fig. 2 Area Under the Curve for IPOS items 3 to 7
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physical palliative needs arise [24, 25]. These are also
possible to and should be captured systematically in clin-
ical practice, using a patient centred outcome measure
and acted upon. In our study, the most stressful non
physical issue was family or friends anxious or worried
(36.3%). Given that Portuguese culture is based on
strong family ties and that decisions are usually made
within the family core, this was not surprising. Feeling
anxious and depressed were the second and third most
stressful issues, even though one of the exclusion criteria
to be approached for invitation to participate in the
study was being clearly in distress (physical or emo-
tional) judged by direct observation of the healthcare
professional. This reinforces the evidence that anxiety is
often present in patients with advanced disease due to
uncertainties in diagnostic, treatment and prognostic,
[13] and, depression is also common among patients
with advanced disease [26]. In our sample the prevalence
of these issues resonates with Ann-Yi S study in terms
of the percentage of patients cared for in the psychology
service [8], although that study was conducted only with
cancer patients. On the other hand, clusters of physical
and non physical symptoms occur and are common in
both cancer and non cancer patients [27, 28]. Also, the
prevalence of depression in the present study was some-
what higher than the one presented in the Antunes
study on screening for depression using one item of the
Palliative care Outcome Scale, namely 17.5% (C.I. 14.1–
21.6%) [20], but lower than the 30% estimated by Hotopf
and colleagues for prevalence of all depressive disorders
in advanced disease [29].
Both AUC for anxiety and depression were acceptable
(70% or above), although both C.I.s lower levels were
slightly below 70%. For cut-off 2/3, both items did not
perform well regarding sensitivity, which means these
might not be good to identify true positive cases. How-
ever, specificity and NPV were good. Both items seem to
be good excluding true negative cases, which is one
component of screening [30]. These results also
reinforce external validity of IPOS.
The main limitation in our study is that the optimal
gold standard to screen for anxiety and depression - psy-
chiatric interview for depression as determined by the
Diagnostic and Statistical Manual of Mental Disorders
(Fifth Edition) was not available to use due to low re-
sources available. The present study used the HADS, a
screening measure well accepted in practice and that has
been used extensively both in practice and research for
several years, nevertheless this is not a diagnostic tool.
Using IPOS systematically could aid clinical teams to
track their progress in assisting patients and families with
physical and non-physical symptoms. Like other screening
tools the Portuguese Integrated Palliative care Outcome
Scale seems to be good for excluding true negative cases
of depression (item 5) and anxiety (item 3) and can be
used to screen patients with advanced disease [30, 31].
Conclusions
Patient centred outcome measures are powerful commu-
nication tools, allowing all those involved in patient care
to use a common language, serving not only patients
and families, but aiding healthcare professionals, health
institutions and policy makers to make evidence sup-
ported decisions and improve patient centred care.
Building evidence of screening properties of these
Fig. 3 Area Under the Curve for Portuguese IPOS item 5, depression
Fig. 4 Area Under the Curve for Portuguese IPOS item 3, anxiety
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measures allows not only for patient clinical care, but
also to conduct more robust research studies. This study
determined screening accuracy properties of the Portu-
guese Integrated Palliative care Outcome Scale for two
psychological related items and shows that this measure
can be used to screen patients with advanced disease.
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